Baird Financial Group, Inc. Innoviva, Inc. Transaction History

Baird Financial Group, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$11.61 - $15.22 $81,049 - $106,250	-6,981 Reduced 18.9%	29,963 $348,000
Q2 2022 Aug 08, 2022	SELL	$14.32 - $19.88 $215,687 - $299,432	-15,062 Reduced 28.96%	36,944 $545,000
Q1 2022 May 13, 2022	BUY	$15.39 - $20.25 $100,558 - $132,313	6,534 Added 14.37%	52,006 $1.01 Million
Q4 2021 Feb 09, 2022	BUY	$15.91 - $18.72 $109,253 - $128,550	6,867 Added 17.79%	45,472 $785,000
Q3 2021 Nov 12, 2021	BUY	$13.06 - $17.24 $216,012 - $285,149	16,540 Added 74.96%	38,605 $646,000
Q2 2021 Aug 11, 2021	SELL	$11.45 - $13.96 $54,009 - $65,849	-4,717 Reduced 17.61%	22,065 $296,000
Q1 2021 May 13, 2021	BUY	$11.06 - $12.87 $111,905 - $130,218	10,118 Added 60.72%	26,782 $320,000
Q4 2020 Feb 11, 2021	BUY	$9.33 - $12.48 $15,487 - $20,716	1,660 Added 11.06%	16,664 $206,000
Q3 2020 Nov 12, 2020	BUY	$10.33 - $14.49 $6,466 - $9,070	626 Added 4.35%	15,004 $157,000
Q2 2020 Oct 22, 2020	SELL	$11.49 - $15.26 $97,021 - $128,855	-8,444 Reduced 37.0%	14,378 $201,000
Q2 2020 Aug 14, 2020	BUY	$11.49 - $15.26 $27,334 - $36,303	2,379 Added 11.64%	22,822 $323,000
Q1 2020 May 14, 2020	SELL	$8.11 - $15.23 $98,025 - $184,085	-12,087 Reduced 37.16%	20,443 $240,000
Q4 2019 Feb 14, 2020	SELL	$10.28 - $14.38 $2.04 Million - $2.86 Million	-198,803 Reduced 85.94%	32,530 $461,000
Q3 2019 Nov 14, 2019	BUY	$10.05 - $14.55 $42,913 - $62,128	4,270 Added 1.88%	231,333 $2.44 Million
Q2 2019 Aug 14, 2019	BUY	$13.1 - $14.95 $2.97 Million - $3.39 Million	227,063 New	227,063 $3.31 Million

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.